CRLComplete Response Letter
Complete Response Letter Sun Pharmaceutical Industries Limited (Nov 24, 2015)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Device constituent and human factors, Clinical efficacy and substantial evidence, Facility inspection and CGMP compliance. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• INFUGEM
